Cost-effectiveness analysis of ubrogepant, rimegepant, and zavegepant for acute migraine treatment vs usual care
Authors:
Posted in Papers / Human Studies|Original Research / November 16-30, 2025
Am J Manag Care. 2025 Nov 1;31(11):e322-e328. doi: 10.37765/ajmc.2025.8922.
PMID: 41289290 | DOI: 10.37765/ajmc.2025.8922
Share this article
Sign Up For An MSC Newsletter
Register to Watch the MSC Emerging Science Contest!
The MSC Emerging Science Contest for Young Investigators will take place on Wednesday, December 13, 2023, from 8-10 PM Eastern (US) time. We welcome those who wish to watch the event as an attendee. Register here to attend, and learn more about the contest here.